CTRI/2013/06/003779招募中2 期
An Applied study of Samavaya as Karana / Padartha in Ayurveda Chikitsa and Darshana
INSTITUTE FOR POST GRADUATE TEACHING AND RESEARCH IN AYURVEDA1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2011年1月8日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Pippalimula tablet is more beneficial than the placebo group
研究概览
简要总结
This study is Randomized placebo control clinical study to evaluate the efficacy of Pippalimula on the Patients suffering from Ama. Routine blood, urine and stool examinations will be carried out to assess the status of Ama and also to rule out any other systemic pathology. Special scoring scale has been prepared based on the information in Ayurvedic classics which will be utilized for assessment and evaluation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients suffering from the state of Ama having the classical symptoms like Aruchi Avipaka Udaragaurava agnimandya etc.
排除标准
- •Patients having age less than 20 years and more than 60 years patients having any major systemic disease Patients having the dominancy of pittaprakriti.
结局指标
主要结局
Pippalimula tablet is more beneficial than the placebo group
时间窗: Till present study i.e. upto february 2012
次要结局
- Lightness and Enthusiasm in the body(February 2012)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)HealthyStressNCT01665170Pascoe Pharmazeutische Praeparate GmbH60
Unknown
不适用
A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel SyndromeIrritable Bowel SyndromeNCT01641224University of Minnesota800
已完成
3 期
Efficacy of Elidel Cream on Erosive Oral Lichen PlanusLichen Planus, OralNCT00130572University Hospital Tuebingen20
已完成
2 期
The Effectiveness of a Caralluma Fimbriata Extract on Stress, Sleep and NeurotransmittersStressSleepNCT05232266RDC Clinical Pty Ltd129
终止
2 期
Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)Irritable Bowel SyndromeNCT01471379Spencer Dorn, MD, MPH2